Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial.
about
Interferon for people with lamivudine-resistant chronic hepatitis B virus infectionAdefovir dipivoxil for adults with lamivudine-resistant chronic hepatitis B virus infectionThe role of interferon therapy in hepatitis BInterferon and lamivudine vs. interferon for hepatitis B e antigen-positive hepatitis B treatment: meta-analysis of randomized controlled trialsA Practical Approach to Management of Chronic Hepatitis BChange of strategies and future perspectives against hepatitis B virus recurrence after liver transplantationThe importance of baseline viral load when assessing relative efficacy in treatment-naïve HBeAg-positive chronic hepatitis B: a systematic review and network meta-analysisOutcome after discontinuation of nucleot(s)ide analogues in chronic hepatitis B: relapse rate and associated factorsDirect acting antivirals for the treatment of chronic viral hepatitisEfficacy and safety of an intravenous monoclonal anti-HBs in chronic hepatitis B patientsIn vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracilTreatment of chronic hepatitis.Association between clinical features and YMDD mutations in patients with chronic hepatitis B following lamivudine therapyIntroduction of lamivudine for the treatment of chronic hepatitis B: expected clinical and economic outcomes based on 4-year clinical trial data.Advancing patient care: integrating new data.The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation.Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization?Hepatitis B in childhood: An update for the paediatricianBiochemical response to lamivudine treatment in HBeAg negative chronic hepatitis B patients in IranDynamic changes of HBV DNA in serum and peripheral blood mononuclear cells of chronic hepatitis patients after lamivudine treatmentHepatitis B: an important public health issue.Profound suppression of hepatitis B virus replication with lamivudine.Hepatitis B e antigen seroconversion: effects of lamivudine alone or in combination with interferon alpha.Lamivudine for hepatitis B in clinical practice.Management of viral hepatitis B.Doctor-to-patient transmission of viral hepatitis B: is it a problem, is there a solution?Antiviral treatment of chronic hepatitis B virus (HBV) infectionsResistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression.Diagnosis and management of pre-core mutant chronic hepatitis B.Current pharmacotherapy for hepatitis B infection.Treatment of viral hepatitis--2001.Therapeutic management of hepatitis B-related cirrhosis.Evolving therapies for the treatment of chronic hepatitis B virus infection.Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection.Systematic review of the literature on comparative effectiveness of antiviral treatments for chronic hepatitis B infection.YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.Chronic hepatitis B: current and future treatment options.One two tandem of lamivudine and inferferon might work for patients with chronic hepatitis B who failed inferferon monotherapy.Therapy of chronic hepatitis B: current challenges and opportunities.
P2860
Q24185973-BB871C0A-491C-4074-9E42-34690B4E60ECQ24187530-0AFF408C-A7E3-4340-9C0E-0660621F8A7BQ24529082-F131C4C4-C2B2-4911-8CC8-6A00A6F85BBEQ24683341-B49EDB68-20DF-4FCF-94D4-898770A587AEQ24810145-04EAEAFC-2349-4EF1-80E6-7629EDF1F4F9Q26784241-96835DEE-5D02-4D96-8CCA-007D9424F2A7Q27016075-F90C5786-DD4C-4498-A867-9FD471F0FF18Q27020938-B6AB2D63-15B0-4C0A-8215-036875871669Q27022216-B4A1E582-1154-4846-BE44-6D06E60A8864Q28203373-7FDC18DF-BE18-4962-8EE4-5D42E9B9E1BCQ28345952-6D86D463-659F-407E-9DAC-74ECD99605EFQ28364240-7B787114-3A19-4A68-8114-871FF3CF5C49Q30390865-146DE572-33DF-4505-AF3C-3922D7AB0E3CQ30689186-9F779D9F-3F04-40EE-838A-7741013AC08CQ31031231-7C448774-075D-4C80-ADF3-BB1B372E7BB3Q33365990-45265B96-CA69-49DC-A624-A8E8A5BBC507Q33574740-AEC7BF54-2047-4B30-A13F-09548EB511B2Q33588605-22732240-ED60-46BE-9BE9-965ABE7DF5C2Q33866030-C33A59F7-ADDF-470E-B3FC-0A7724B4C558Q33867462-7C282B01-C6D3-4FD6-BF14-073FF129846BQ33947147-06773DC3-9D20-4233-BEF1-7EA1E03C0503Q33947154-3E702547-5A14-47DF-B1D4-B7152F5D32FAQ33947160-EEB74B99-967A-40DA-B84B-79F841B8EB48Q33947173-E31DBE85-49D2-4A92-8C62-1ACC8A4179ECQ33959006-98E563F3-705E-4DDB-BD2E-B3A8FA0C1D4DQ33962260-0A7BAAA3-1DA3-4ECF-910E-36F2FB7C57F6Q34223779-C707DA1A-9DA5-4E90-8B39-AB8E8FE82440Q34299035-EAFD3BCB-DE2B-440F-B04C-625E17EB5D6CQ34365464-11D5F355-8F26-4023-A099-7C78BF315773Q34368364-AB5FA3EE-E174-4E36-9CA2-7A85E0DCE17DQ34390231-D8C9E0D6-A888-49B1-9143-178D5655E5E1Q34390398-2D5F43E5-2D98-4969-AA6F-405FA09FA1A0Q34434784-D0AF654C-4F13-4C10-A0A6-9612EE27BBF5Q34519117-C3A1C8C3-AB2B-487A-A51F-91A682F028DDQ34584406-E7A0C867-4CD5-4DB5-BCC2-234F043ACF8AQ34594403-DE0D3901-09BF-4051-9724-E2561CB63606Q34604733-AA0863AF-E368-4C03-8EAD-2A1FF6FB66A1Q34687438-06981F2A-722A-4462-9545-28AB06145080Q34928150-6520279B-9660-478D-8E75-94EE4754D4A7Q34996613-49306D67-176D-4C1E-930F-02338781899B
P2860
Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Lamivudine and alpha interfero ...... infection: a randomised trial.
@ast
Lamivudine and alpha interfero ...... infection: a randomised trial.
@en
type
label
Lamivudine and alpha interfero ...... infection: a randomised trial.
@ast
Lamivudine and alpha interfero ...... infection: a randomised trial.
@en
prefLabel
Lamivudine and alpha interfero ...... infection: a randomised trial.
@ast
Lamivudine and alpha interfero ...... infection: a randomised trial.
@en
P2093
P2860
P356
P1433
P1476
Lamivudine and alpha interfero ...... infection: a randomised trial.
@en
P2093
J Cianciara
J Heathcote
S W Schalm
P2860
P304
P356
10.1136/GUT.46.4.562
P407
P577
2000-04-01T00:00:00Z